MIF and neoplasm: The high concentrations of RANKL, macrophage migration inhibitory factor (MIF), and osteoprotegerin (OPG) in the peripheral blood of patients may contribute to the process of intravasation, angiogenesis, survival, and epithelial-mesenchymal transition of circulating tumor cells 74.